WHO ICTRP trial
Clinical study for anti-SLAMF3 CAR-T in the treatment of refractory or recurrent…
ChiCTR2000033568 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000033568 |
|---|---|
| Public title | Clinical study for anti-SLAMF3 CAR-T in the treatment of refractory or recurrent SLAMF3+ hematological malignancies |
| Scientific title | Clinical study for anti-SLAMF3 CAR-T in the treatment of refractory or recurrent SLAMF3+ hematological malignancies |
| Primary sponsor | The Affiliated Hospital of Xuzhou Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Hematological malignancies |
| Interventions | experimental group:anti-SLAMF3 CAR-T |
| Registration date | Jun 5, 2020 |
| Target size | experimental group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: